Author: Ante


Posted on / by Ante / in 2020 PR

February 2020 – Milestone in novel therapy of M. Basedow reached

AdvanceCOR GmbH gibt den erfolgreichen Abschluß der präklinischen Untersuchungen des Schilddrüsen-stimulierenden Hormonrezeptor-(TSHR)-Peptids 19 zur Behandlung der autoimmunen Schilddrüsen-Überfunktion (Hyperthyreose durch Morbus Basedow) und dabei auftretender Augenerkrankung (endokrine Orbitopathie) bekannt. (…)

Posted on / by Ante / in 2022 PR

August 2022 – Revacept – Protects during carotid artery surgery

Good news from vascular medicine: the innovative drug Revacept can protect people with narrowed carotid arteries from both further strokes and dangerous bleeding. Thanks to this completely new dual efficacy, Revacept is ideal for preventing complications after stroke prevention surgery on narrowed carotid arteries. (…)